Pfizer (PFE) Receives a Hold from Credit Suisse
Credit Suisse analyst Lorenzo Biasio maintained a Hold rating on
Pfizer (PFE – Research Report) yesterday and set a price target of
$54.00. The company's shares closed last Monday at $50.67.
According to TipRanks.com, Biasio is a 4-star analyst with an
average return of 7.1% and a 61.3% success rate. Biasio covers the
Healthcare sector, focusing on stocks such as Coherus Biosciences,
Intuitive Surgical, and Boston Scientific. Pfizer has an analyst
consensus of Moderate Buy, with a price target consensus of $58.92,
which is a 18.1% upside from current levels. In a report issued on
May 3, Mizuho Securities also maintained a Hold rating on the stock
with a $55.
から 6 2022 まで 7 2022
から 7 2021 まで 7 2022